ArticleMethods in molecular biology (Clifton, N.J.)2025
Preparation of Human Trabecular Meshwork Cells for Metabolomic Studies.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The trabecular meshwork (TM) is a sieve-like structure within the anterior chamber of the eye responsible for the drainage of aqueous humor and regulation of intraocular pressure (IOP). Dysfunctional TM causes resistance to aqueous outflow and ocular hypertension (elevated IOP), the only modifiable risk factor in the development of glaucoma. The study of metabolites, small bioactive compounds derived from metabolic processes, is a powerful tool for gaining insights into the mechanism of disease and development of drug therapies and biomarkers. Metabolomic studies of primary trabecular meshwork cells can yield insights into the pathophysiology of ocular hypertension as well as identify novel targets for the treatment of glaucoma. This protocol chapter will detail the dissection, culturing, and preparation of human trabecular meshwork cells for metabolite extraction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.